Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,203 | 283 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $780.04 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $709.97 | 39 | $0 (2024) |
| Lilly USA, LLC | $588.07 | 47 | $0 (2024) |
| ABBVIE INC. | $360.12 | 30 | $0 (2024) |
| GlaxoSmithKline, LLC. | $339.00 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $336.78 | 26 | $0 (2022) |
| Abbott Laboratories | $150.15 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $119.96 | 6 | $0 (2023) |
| PFIZER INC. | $109.33 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $99.02 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $767.78 | 47 | AstraZeneca Pharmaceuticals LP ($209.72) |
| 2023 | $959.71 | 59 | AstraZeneca Pharmaceuticals LP ($159.72) |
| 2022 | $1,282 | 99 | Novo Nordisk Inc ($298.14) |
| 2021 | $1,193 | 78 | Lilly USA, LLC ($211.89) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: PAIN | ||||||
| 08/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 08/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: PAIN | ||||||
| 07/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Gastroenterology | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 122 | 164 | $2,664 | $1,360 |
| 2022 | 1 | 74 | 79 | $711.00 | $232.32 |
| 2020 | 5 | 165 | 193 | $23,023 | $4,117 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 105 | 146 | $1,314 | $1,226 | 93.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 18 | $1,350 | $133.79 | 9.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 74 | 79 | $711.00 | $232.32 | 32.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 79 | $12,087 | $2,311 | 19.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 35 | $7,875 | $1,370 | 17.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 14 | $1,288 | $213.01 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 43 | 47 | $423.00 | $136.44 | 32.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 15 | 18 | $1,350 | $86.53 | 6.4% |
About Brian Ham, ARNP
Brian Ham, ARNP is a Adult Health healthcare provider based in Chattahoochee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053505909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Ham, ARNP has received a total of $4,203 in payments from pharmaceutical and medical device companies, with $767.78 received in 2024. These payments were reported across 283 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,203).
As a Medicare-enrolled provider, Ham has provided services to 361 Medicare beneficiaries, totaling 436 services with total Medicare billing of $5,710. Data is available for 3 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Chattahoochee, FL
- Active Since 09/04/2007
- Last Updated 01/27/2022
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1053505909
Products in Payments
- BREZTRI (Drug) $434.82
- Ozempic (Drug) $424.84
- STIOLTO RESPIMAT (Drug) $321.73
- Rybelsus (Drug) $320.05
- TRELEGY ELLIPTA (Drug) $308.34
- MOUNJARO (Drug) $277.54
- TRULICITY (Drug) $200.11
- VRAYLAR (Drug) $193.29
- NURTEC ODT (Drug) $134.18
- AIRSUPRA (Drug) $133.51
- FARXIGA (Drug) $110.85
- EMGALITY (Drug) $110.42
- UBRELVY (Drug) $105.44
- Korlym (Drug) $97.41
- FreeStyle Libre 2 (Device) $87.68
- VOQUEZNA (Drug) $82.94
- XIFAXAN (Drug) $79.74
- BELSOMRA (Drug) $79.54
- LEQVIO (Drug) $68.39
- FREESTYLE LIBRE 3 (Device) $62.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.